Krajska nemocnice Liberec a.s. — Clinical Trial Site

42 Registered trials

14 Currently recruiting

Organisation

Krajska nemocnice Liberec a.s.

Location

Liberec (neclenene Mesto), Czechia

Identifier

ORG-100046013

Address

Husova 357/10, Liberec I-Stare Mesto, 460 01, Czechia

Departments

2322: Kardiocentrum
3054:Kardiocentrum
Anesteziologicko resuscitační oddělení, Ambulance chronické bolesti
Cardiology Department
Center of Anesthesiology, Resuscitation and Intensive Medicine
Department of Emergency
Department of Urology/Oncology
Gastroenterologie
Kardiocentrum
Kardiologické oddělení
Komplexní cerebrovaskularní centrum - Neurologický JIP A
Komplexní onkologické centrum
Komplexní onkologické centrum, Oddělení klinické onkologie
N/A
NA
Neurologie
nkologicka klinika/Oncology clinic
Odd. Klinické onkologie Komplexní onkologické centrum
Oddělení gastroenterologie a hepatologie
Oddělení infekčních nemocí
Oddělení invazivní kardiologie
Oddeleni klinicke onkologie
Oncology
Plicní oddělení
Urologie
Urology
Urology department

Clinical trials at this site (42)

Search interface

An Efficacy and Safety Study of JNJ56021927 (ARN509) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS Ended

2023-505246-26-00 High- or very-high risk, localized or locally advanced 5 2016-01-27
A Study of Apalutamide Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants with mHSPC Ended

2023-508607-20-00 Metastatic Hormone-sensitive Prostate Cancer 5 2015-11-27
Effects of NNC0194-0499, cagrilintide, and semaglutide alone or in combinations on liver damage and alcohol use in people with alcohol-relat… Ended

2023-508170-28-00 alcohol-related liver disease 4 2024-08-07
A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants with Cirrhosis-ZEAL-UNLOCK Ended

2023-506893-11-00 Cirrhosis of the liver is a condition in which the live 4 2024-04-19
A proof of concept and dose-finding study of XXB750 in patients with heart failure Ended

2023-504678-39-00 Heart Failure 4 2024-03-13
Dose-response characterization of VER-01 in the treatment of patients with chronic non-specific low back pain Ended

2023-507358-34-00 For the treatment of patients with chronic non-specific 4 2024-02-13
A large global trial to evaluate the efficacy and safety of milvexian in reducing recurrent cardiovascular events in patients after a heart … Ended

2022-501418-69-00 Acute Coronary Syndrome 5 2023-11-21
A Phase 2b Study of MK-6024 in Adults with Precirrhotic Nonalcoholic Steatohepatitis Ended

2022-502647-35-00 Non-alcoholic steatohepatitis 4 2023-09-01
An 18-month study to assess joint outcomes in patients with haemophilia A or B on prophylaxis with efmoroctocog alfa or eftrenonacog alfa Ended

2022-502921-16-00 Hemophilia A and B 6 2023-07-21
Study to Assess the Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in the Treatment of C… Ended

2024-515463-55-00 Complicated urinary tract infection (cUTI) and acute un 5 2023-05-18
Long-term Efficacy and Safety of Tozorakimab in Participants with Chronic Obstructive Pulmonary Disease with a History of Exacerbations. Ended

2022-501063-41-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2023-04-20
Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68) Ended

2024-517612-29-00 acute heart failure 11 2023-02-14
A study to test asundexian for preventing a stroke caused by a clot in participants after an acute ischemic stroke or after a high-risk tran… Ended

2023-503793-20-00 Prevention of ischemic stroke in patients post acute no 5 2023-01-18
A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolis… Ended

2023-503794-38-00 Prevention of stroke or systemic embolism in atrial fib 5 2022-11-24
A Phase 3, randomized, double-blind, placebo-controlled, multicenter study of IV FDY-5301 in patients with a myocardial infarction (STEMI) Ended

2024-514372-40-00 Anterior ST-Elevation Myocardial Infarction 5 2022-04-12
Study to assess efficacy, safety, and tolerability of Tozorakimab in patients with symptomatic chronic obstructive pulmonary disease (COPD) … Ended

2023-503571-19-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2022-01-20
Research study on whether a combination of 2 medicines (NNC0194-0499 and Semaglutide) works in people with non-alcoholic steatohepatitis (NA… Ended

2023-506961-74-00 Non-alcoholic steatohepatitis (NASH) 4 2021-08-31
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke Ended

2023-503673-38-00 Adults at high risk of cardiovascular events without pr 5 2019-05-24